Category: Blog
-
FDA approves Johnson & Johnson booster
U.S. health regulators significantly widened the nation’s Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson & Johnson vaccines and also saying people can get a shot that is different from what they had previously received. The moves, announced by the Food and Drug Administration on Wednesday, will make boosters available to the majority of adults who…
-
Exxon considers abandoning big oil and gas projects
This is why I voted against these new board members. Oil and gas will continue to have its place for decades to come and investing in new sources, regardless of where the world goes with nuclear and renewables, is key to an energy company’s growth. Members of the board—which includes three directors successfully nominated by…
-
Johnson & Johnson post 11% increase in revenue
The company’s revenue rose 11% year over year in the third quarter to $23.34 billion. Its results are closely watched in the healthcare sector because its products span multiple categories. Medical-device sales grew 7.6% amid a higher level of surgical procedures. Pharmaceutical sales were up 14%, the result of more prescriptions of drugs for multiple…
-
Proctor & Gamble raising prices on household staples
Inflation continues to ripple through all economic sectors The maker of Tide detergent and Gillette razors said it would start charging more for certain beauty, oral care and grooming products such as razors. The price increases come in addition to earlier moves to start charging more for staples from diapers to toilet paper. P&G, which released quarterly…
-
Energymageddon
Are we headed towards a 1970’s style energy crisis, J&J talc liability bankruptcy, Microsoft shuts down LinkedIn in China, and much more!
-
FDA advisors unanimously authorize Johnson & Johnson $JNJ booster
Advisers to the Food and Drug Administration voted unanimously Friday to recommend the agency authorize an extra dose of Johnson & Johnson’s Covid-19 vaccine, to shore up protection against the coronavirus. The panel of outside doctors and experts voted 19-0 to recommend that all adults who received a first dose of the J&J vaccine should get the second…